# High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/high-risk-of-myelodysplastic-syndrome-and-acute-myeloid-leukemia-after-177lu/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bertrand Brieau,Olivia Hentic,Rachida Lebtahi,Maxime Palazzo,Makrem Ben Reguiga,Vinciane Rebours,Frédérique Maire,Pascal Hammel,Philippe Ruszniewski,Pierre Fenaux |
| Citations | 62 |
| DOI | 10.1530/erc-15-0543 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://erc.bioscientifica.com/downloadpdf/journals/erc/23/5/L17.pdf |
| OpenAlex ID | https://openalex.org/W2463185305 |
| PMID | 26932783 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Bertrand Brieau](https://scholariq.org/researchers/bertrand-brieau/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.